Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma

Asian J Surg. 2024 May 13:S1015-9584(24)00843-1. doi: 10.1016/j.asjsur.2024.04.161. Online ahead of print.

Authors

Jianjun Ye¹, Mengni Zhang², Yige Bao³

Affiliations

¹ Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China; West China School of Medicine, Sichuan University, Chengdu, China.
² Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
³ Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: yige.bao@scu.edu.cn.

PMID: 38744655
DOI: 10.1016/j.asjsur.2024.04.161

No abstract available

Keywords: HER2 expression; Heterogeneity; Upper tract urothelial carcinoma.

Publication types

Letter